Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jonathan Wolleben's Stock Ratings
JMP Securities Analyst
Jonathan Wolleben is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/14/2025
Overall Average Return
16.2%
Smart Score
Overall Average Return Percentile
73rd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/27/2025 | DBVT | Buy Now | DBV Technologies | $9.53 | 120.36% | Jonathan Wolleben72% | $15 → $21 | Maintains | Market Outperform | Get Alert |
| 05/23/2025 | AURA | Buy Now | Aura Biosciences | $6.40 | 196.87% | Jonathan Wolleben72% | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2025 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 540.2% | Jonathan Wolleben72% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/09/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 50.73% | Jonathan Wolleben72% | $74 → $76 | Maintains | Market Outperform | Get Alert |
| 04/24/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 55.41% | Jonathan Wolleben72% | $443 → $443 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/10/2025 | MBX | Buy Now | MBX Biosciences | $10.50 | 261.9% | Jonathan Wolleben72% | → $38 | Initiates | → Market Outperform | Get Alert |
| 04/02/2025 | ALT | Buy Now | Altimmune | $6.95 | 259.71% | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/28/2025 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 540.2% | Jonathan Wolleben72% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/26/2025 | AURA | Buy Now | Aura Biosciences | $6.40 | 196.87% | Jonathan Wolleben72% | $21 → $19 | Maintains | Market Outperform | Get Alert |
| 03/26/2025 | KALV | Buy Now | KalVista Pharma | $13.42 | 41.59% | Jonathan Wolleben72% | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/26/2025 | AURA | Buy Now | Aura Biosciences | $6.40 | 196.87% | Jonathan Wolleben72% | $21 → $19 | Maintains | Market Outperform | Get Alert |
| 03/21/2025 | SKYE | Buy Now | Skye Bioscience | $2.12 | 607.55% | Jonathan Wolleben72% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/14/2025 | ALT | Buy Now | Altimmune | $6.95 | 259.71% | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/10/2025 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | 11.6% | Jonathan Wolleben72% | $61 → $61 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/04/2025 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 117.14% | Jonathan Wolleben72% | $22 → $19 | Maintains | Market Outperform | Get Alert |
| 03/04/2025 | DBVT | Buy Now | DBV Technologies | $9.53 | 4.93% | Jonathan Wolleben72% | $10 → $10 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/03/2025 | PHVS | Buy Now | Pharvaris | $18.81 | 192.4% | Jonathan Wolleben72% | $55 → $55 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/03/2025 | KALV | Buy Now | KalVista Pharma | $13.42 | 41.59% | Jonathan Wolleben72% | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/03/2025 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 76.3% | Jonathan Wolleben72% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/03/2025 | ATXS | Buy Now | Astria Therapeutics | $5.93 | 338.45% | Jonathan Wolleben72% | $26 → $26 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/28/2025 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 323.98% | Jonathan Wolleben72% | $91 → $87 | Maintains | Market Outperform | Get Alert |
| 02/28/2025 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 191.67% | Jonathan Wolleben72% | $92 → $91 | Maintains | Market Outperform | Get Alert |
| 02/25/2025 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 76.3% | Jonathan Wolleben72% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/24/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 46.77% | Jonathan Wolleben72% | $74 → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/07/2025 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | 6.11% | Jonathan Wolleben72% | $58 → $58 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/31/2025 | PHVS | Buy Now | Pharvaris | $18.81 | 192.4% | Jonathan Wolleben72% | $46 → $55 | Maintains | Market Outperform | Get Alert |
| 01/31/2025 | KALV | Buy Now | KalVista Pharma | $13.42 | 41.59% | Jonathan Wolleben72% | → $19 | Initiates | → Market Outperform | Get Alert |
| 01/31/2025 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 76.3% | Jonathan Wolleben72% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/31/2025 | ATXS | Buy Now | Astria Therapeutics | $5.93 | 338.45% | Jonathan Wolleben72% | → $26 | Initiates | → Market Outperform | Get Alert |
| 01/10/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 49.79% | Jonathan Wolleben72% | $427 → $427 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/10/2025 | DBVT | Buy Now | DBV Technologies | $9.53 | 4.93% | Jonathan Wolleben72% | $10 → $10 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/23/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $61.30 | 22.35% | Jonathan Wolleben72% | $75 → $75 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/19/2024 | SVRA | Buy Now | Savara | $2.18 | 312.84% | Jonathan Wolleben72% | $9 → $9 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/18/2024 | HGV | Buy Now | Hilton Grand Vacations | $39.38 | 26.97% | Jonathan Wolleben72% | $55 → $50 | Maintains | Market Outperform | Get Alert |
| 12/18/2024 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 343.47% | Jonathan Wolleben72% | $91 → $91 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/16/2024 | CSGP | Buy Now | CoStar Gr | $81.87 | 9.93% | Jonathan Wolleben72% | $90 → $90 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/16/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 178.85% | Jonathan Wolleben72% | $87 → $87 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/16/2024 | ABNB | Buy Now | Airbnb | $136.20 | — | Jonathan Wolleben72% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 12/12/2024 | PRQR | Buy Now | ProQR Therapeutics | $1.88 | 325.53% | Jonathan Wolleben72% | $8 → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/11/2024 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 3948.58% | Jonathan Wolleben72% | $3 → $3 | Downgrade | Market Outperform → Market Perform | Get Alert |
| 12/10/2024 | DBVT | Buy Now | DBV Technologies | $9.53 | 4.93% | Jonathan Wolleben72% | $10 → $10 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/05/2024 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 76.3% | Jonathan Wolleben72% | $16 → $18 | Maintains | Market Outperform | Get Alert |
| 11/13/2024 | SPOT | Buy Now | Spotify Technology | $712.45 | -31.93% | Jonathan Wolleben72% | $420 → $485 | Downgrade | Buy → Accumulate | Get Alert |
| 10/01/2024 | SVRA | Buy Now | Savara | $2.18 | 312.84% | Jonathan Wolleben72% | $9 → $9 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/27/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 156.41% | Jonathan Wolleben72% | $80 → $80 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/26/2024 | ALLK | Buy Now | Allakos | — | — | Jonathan Wolleben72% | $3 → $3 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/24/2024 | DBVT | Buy Now | DBV Technologies | $9.53 | -47.53% | Jonathan Wolleben72% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/17/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $61.30 | 4.4% | Jonathan Wolleben72% | → $64 | Initiates | → Market Outperform | Get Alert |
| 09/13/2024 | AURA | Buy Now | Aura Biosciences | $6.40 | 259.38% | Jonathan Wolleben72% | $19 → $23 | Maintains | Market Outperform | Get Alert |
| 09/10/2024 | SKYE | Buy Now | Skye Bioscience | $2.12 | 607.55% | Jonathan Wolleben72% | → $15 | Initiates | → Market Outperform | Get Alert |
| 09/09/2024 | SVRA | Buy Now | Savara | $2.18 | 312.84% | Jonathan Wolleben72% | $9 → $9 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/28/2024 | AURA | Buy Now | Aura Biosciences | $6.40 | 196.87% | Jonathan Wolleben72% | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/15/2024 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 338.36% | Jonathan Wolleben72% | $48 → $32 | Maintains | Market Outperform | Get Alert |
| 08/13/2024 | SVRA | Buy Now | Savara | $2.18 | 312.84% | Jonathan Wolleben72% | $10 → $9 | Maintains | Market Outperform | Get Alert |
| 08/09/2024 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 319.1% | Jonathan Wolleben72% | $91 → $86 | Maintains | Market Outperform | Get Alert |
| 08/07/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -21.33% | Jonathan Wolleben72% | $45 → $43 | Maintains | Market Outperform | Get Alert |
| 08/06/2024 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 56.71% | Jonathan Wolleben72% | $15 → $16 | Maintains | Market Outperform | Get Alert |
| 07/31/2024 | DBVT | Buy Now | DBV Technologies | $9.53 | -47.53% | Jonathan Wolleben72% | $4 → $5 | Maintains | Market Outperform | Get Alert |
| 07/16/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 35.06% | Jonathan Wolleben72% | $381 → $385 | Maintains | Market Outperform | Get Alert |
| 06/26/2024 | ALLK | Buy Now | Allakos | — | — | Jonathan Wolleben72% | $3 → $3 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/18/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 34.87% | Jonathan Wolleben72% | $66 → $68 | Maintains | Market Outperform | Get Alert |
| 06/17/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -17.67% | Jonathan Wolleben72% | $45 → $45 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/07/2024 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 557.53% | Jonathan Wolleben72% | $48 → $48 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/04/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 156.41% | Jonathan Wolleben72% | $80 → $80 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/31/2024 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 771.08% | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/24/2024 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 557.53% | Jonathan Wolleben72% | $48 → $48 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/21/2024 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 771.08% | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/10/2024 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 343.47% | Jonathan Wolleben72% | $91 → $91 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/10/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 156.41% | Jonathan Wolleben72% | $80 → $80 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/10/2024 | ALT | Buy Now | Altimmune | $6.95 | 245.32% | Jonathan Wolleben72% | $25 → $24 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 30.9% | Jonathan Wolleben72% | $72 → $66 | Maintains | Market Outperform | Get Alert |
| 05/08/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -17.67% | Jonathan Wolleben72% | $42 → $45 | Maintains | Market Outperform | Get Alert |
| 05/08/2024 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 151.43% | Jonathan Wolleben72% | $24 → $22 | Maintains | Market Outperform | Get Alert |
| 05/08/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 33.66% | Jonathan Wolleben72% | $397 → $381 | Maintains | Market Outperform | Get Alert |
| 05/07/2024 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 46.91% | Jonathan Wolleben72% | $14 → $15 | Maintains | Market Outperform | Get Alert |
| 05/06/2024 | SVRA | Buy Now | Savara | $2.18 | 266.97% | Jonathan Wolleben72% | $8 → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/19/2024 | SVRA | Buy Now | Savara | $2.18 | 266.97% | Jonathan Wolleben72% | $8 → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/19/2024 | RLYB | Buy Now | Rallybio | $0.37 | 2063.92% | Jonathan Wolleben72% | $8 → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/18/2024 | SVRA | Buy Now | Savara | $2.18 | 266.97% | Jonathan Wolleben72% | $8 → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/18/2024 | RLYB | Buy Now | Rallybio | $0.37 | 2063.92% | Jonathan Wolleben72% | $8 → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/16/2024 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 174.29% | Jonathan Wolleben72% | $24 → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/11/2024 | PHVS | Buy Now | Pharvaris | $18.81 | 165.82% | Jonathan Wolleben72% | $49 → $50 | Maintains | Market Outperform | Get Alert |
| 03/28/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 156.41% | Jonathan Wolleben72% | $80 → $80 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/20/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 156.41% | Jonathan Wolleben72% | $60 → $80 | Maintains | Market Outperform | Get Alert |
| 03/15/2024 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 771.08% | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/15/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 39.27% | Jonathan Wolleben72% | $351 → $397 | Maintains | Outperform | Get Alert |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 3948.58% | Jonathan Wolleben72% | $8 → $3 | Maintains | Market Outperform | Get Alert |
| 03/14/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 42.8% | Jonathan Wolleben72% | $69 → $72 | Maintains | Outperform | Get Alert |
| 03/13/2024 | RLYB | Buy Now | Rallybio | $0.37 | 2063.92% | Jonathan Wolleben72% | $8 → $8 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 174.29% | Jonathan Wolleben72% | $24 → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/13/2024 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 540.2% | Jonathan Wolleben72% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/12/2024 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 771.08% | Jonathan Wolleben72% | $25 → $25 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/12/2024 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 174.29% | Jonathan Wolleben72% | $12 → $24 | Maintains | Market Outperform | Get Alert |
| 03/11/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -23.16% | Jonathan Wolleben72% | $42 → $42 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/08/2024 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 343.47% | Jonathan Wolleben72% | $91 → $91 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/29/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 36.85% | Jonathan Wolleben72% | $64 → $69 | Maintains | Market Outperform | Get Alert |
| 02/29/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 92.31% | Jonathan Wolleben72% | $50 → $60 | Maintains | Market Outperform | Get Alert |
| 02/23/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 21.73% | Jonathan Wolleben72% | $347 → $347 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/16/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 21.73% | Jonathan Wolleben72% | $347 → $347 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/15/2024 | SVRA | Buy Now | Savara | $2.18 | 266.97% | Jonathan Wolleben72% | → $8 | Initiates | → Market Outperform | Get Alert |
| 02/14/2024 | PHVS | Buy Now | Pharvaris | $18.81 | 160.5% | Jonathan Wolleben72% | $49 → $49 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/13/2024 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 771.08% | Jonathan Wolleben72% | $17 → $25 | Maintains | Market Outperform | Get Alert |
| 02/07/2024 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 530.14% | Jonathan Wolleben72% | $47 → $46 | Maintains | Market Outperform | Get Alert |
| 02/07/2024 | RLYB | Buy Now | Rallybio | $0.37 | 2063.92% | Jonathan Wolleben72% | $16 → $8 | Maintains | Market Outperform | Get Alert |
| 01/23/2024 | PHVS | Buy Now | Pharvaris | $18.81 | 160.5% | Jonathan Wolleben72% | $40 → $49 | Maintains | Market Outperform | Get Alert |
| 01/23/2024 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 543.84% | Jonathan Wolleben72% | $31 → $47 | Maintains | Market Outperform | Get Alert |
| 01/22/2024 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 543.84% | Jonathan Wolleben72% | $31 → $47 | Maintains | Market Outperform | Get Alert |
| 01/17/2024 | ALLK | Buy Now | Allakos | — | — | Jonathan Wolleben72% | $10 → $3 | Maintains | Market Outperform | Get Alert |
| 01/11/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 26.93% | Jonathan Wolleben72% | $64 → $64 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/05/2023 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 324.66% | Jonathan Wolleben72% | → $31 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/28/2023 | ALLK | Buy Now | Allakos | — | — | Jonathan Wolleben72% | → $10 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/20/2023 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 343.47% | Jonathan Wolleben72% | → $91 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/15/2023 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 343.47% | Jonathan Wolleben72% | $90 → $91 | Maintains | Market Outperform | Get Alert |
| 11/14/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 34.36% | Jonathan Wolleben72% | → $383 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/14/2023 | ALLK | Buy Now | Allakos | — | — | Jonathan Wolleben72% | $11 → $10 | Maintains | Market Outperform | Get Alert |
| 11/10/2023 | AURA | Buy Now | Aura Biosciences | $6.40 | 196.87% | Jonathan Wolleben72% | $21 → $19 | Maintains | Market Outperform | Get Alert |
| 11/03/2023 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -32.31% | Jonathan Wolleben72% | $35 → $37 | Maintains | Market Outperform | Get Alert |
| 10/19/2023 | GPCR | Buy Now | Structure Therapeutics | $20.52 | 338.6% | Jonathan Wolleben72% | → $90 | Initiates | → Market Outperform | Get Alert |
| 10/18/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 38.83% | Jonathan Wolleben72% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/09/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 38.83% | Jonathan Wolleben72% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/27/2023 | ALLK | Buy Now | Allakos | — | — | Jonathan Wolleben72% | → $11 | Initiates | → Market Outperform | Get Alert |
| 09/20/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $50.42 | 38.83% | Jonathan Wolleben72% | → $70 | Initiates | → Market Outperform | Get Alert |
| 09/05/2023 | RLYB | Buy Now | Rallybio | $0.37 | 4227.83% | Jonathan Wolleben72% | → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/16/2023 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 10696.22% | Jonathan Wolleben72% | $7 → $8 | Maintains | Outperform | Get Alert |
| 08/15/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 492.33% | Jonathan Wolleben72% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/15/2023 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 540.2% | Jonathan Wolleben72% | → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/09/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 34.62% | Jonathan Wolleben72% | $43 → $42 | Maintains | Market Outperform | Get Alert |
| 08/08/2023 | SGMT | Buy Now | Sagimet Biosciences | $7.30 | 310.96% | Jonathan Wolleben72% | → $30 | Initiates | → Market Outperform | Get Alert |
| 08/01/2023 | DBVT | Buy Now | DBV Technologies | $9.53 | -58.03% | Jonathan Wolleben72% | → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/25/2023 | RLYB | Buy Now | Rallybio | $0.37 | 4227.83% | Jonathan Wolleben72% | → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/12/2023 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 540.2% | Jonathan Wolleben72% | → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/12/2023 | ALT | Buy Now | Altimmune | $6.95 | 115.83% | Jonathan Wolleben72% | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/06/2023 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -35.97% | Jonathan Wolleben72% | $28 → $35 | Maintains | Market Outperform | Get Alert |
| 06/26/2023 | RLYB | Buy Now | Rallybio | $0.37 | 4227.83% | Jonathan Wolleben72% | $26 → $16 | Maintains | Market Outperform | Get Alert |
| 06/15/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 37.82% | Jonathan Wolleben72% | → $43 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 37.14% | Jonathan Wolleben72% | → $12 | Reiterates | → Market Outperform | Get Alert |
| 05/17/2023 | PRQR | Buy Now | ProQR Therapeutics | $1.88 | 219.15% | Jonathan Wolleben72% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2023 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 9346.69% | Jonathan Wolleben72% | → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 422.65% | Jonathan Wolleben72% | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/12/2023 | WMG | Buy Now | Warner Music Gr | $26.70 | -10.11% | Jonathan Wolleben72% | $25 → $24 | Maintains | Outperform | Get Alert |
| 05/11/2023 | DBVT | Buy Now | DBV Technologies | $9.53 | -58.03% | Jonathan Wolleben72% | → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/11/2023 | ALT | Buy Now | Altimmune | $6.95 | 115.83% | Jonathan Wolleben72% | $15 → $15 | Reinstates | Market Outperform → Market Outperform | Get Alert |
| 05/09/2023 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 37.14% | Jonathan Wolleben72% | $11 → $12 | Maintains | Outperform | Get Alert |
| 05/08/2023 | PHVS | Buy Now | Pharvaris | $18.81 | 6.33% | Jonathan Wolleben72% | → $20 | Reiterates | → Market Outperform | Get Alert |
| 05/05/2023 | DBVT | Buy Now | DBV Technologies | $9.53 | -58.03% | Jonathan Wolleben72% | → $4 | Maintains | Market Outperform | Get Alert |
| 05/05/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 37.82% | Jonathan Wolleben72% | $41 → $43 | Maintains | Outperform | Get Alert |
| 04/28/2023 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 668.25% | Jonathan Wolleben72% | → $6 | Reiterates | → Market Outperform | Get Alert |
| 04/27/2023 | DBVT | Buy Now | DBV Technologies | $9.53 | -58.03% | Jonathan Wolleben72% | → $4 | Reiterates | → Market Outperform | Get Alert |
| 04/06/2023 | PHVS | Buy Now | Pharvaris | $18.81 | 6.33% | Jonathan Wolleben72% | $23 → $20 | Maintains | Market Outperform | Get Alert |
| 03/31/2023 | ALT | Buy Now | Altimmune | $6.95 | 115.83% | Jonathan Wolleben72% | → $15 | Reiterates | → Market Outperform | Get Alert |
| 03/30/2023 | PRQR | Buy Now | ProQR Therapeutics | $1.88 | 219.15% | Jonathan Wolleben72% | → $6 | Reiterates | → Market Outperform | Get Alert |
| 03/22/2023 | ALT | Buy Now | Altimmune | $6.95 | 274.1% | Jonathan Wolleben72% | → $26 | Reiterates | → Market Outperform | Get Alert |
| 03/17/2023 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 9346.69% | Jonathan Wolleben72% | → $7 | Maintains | Market Outperform | Get Alert |
| 03/16/2023 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -48.77% | Jonathan Wolleben72% | $31 → $28 | Maintains | Market Outperform | Get Alert |
| 03/16/2023 | AURA | Buy Now | Aura Biosciences | $6.40 | 290.63% | Jonathan Wolleben72% | $30 → $25 | Maintains | Outperform | Get Alert |
| 03/14/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 422.65% | Jonathan Wolleben72% | $15 → $15 | Maintains | Market Outperform | Get Alert |
| 03/10/2023 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 668.25% | Jonathan Wolleben72% | $7 → $6 | Maintains | Market Outperform | Get Alert |
| 03/08/2023 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -43.29% | Jonathan Wolleben72% | $21 → $31 | Maintains | Market Outperform | Get Alert |
| 03/08/2023 | DBVT | Buy Now | DBV Technologies | $9.53 | -58.03% | Jonathan Wolleben72% | → $4 | Reiterates | → Market Outperform | Get Alert |
| 03/07/2023 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 25.71% | Jonathan Wolleben72% | $12 → $11 | Maintains | Market Outperform | Get Alert |
| 03/03/2023 | DBVT | Buy Now | DBV Technologies | $9.53 | -58.03% | Jonathan Wolleben72% | → $4 | Reiterates | → Market Outperform | Get Alert |
| 03/01/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 422.65% | Jonathan Wolleben72% | → $15 | Maintains | Market Outperform | Get Alert |
| 03/01/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 31.41% | Jonathan Wolleben72% | $50 → $41 | Maintains | Market Outperform | Get Alert |
| 02/27/2023 | PHVS | Buy Now | Pharvaris | $18.81 | 22.28% | Jonathan Wolleben72% | → $23 | Reiterates | → Market Outperform | Get Alert |
| 02/22/2023 | RLYB | Buy Now | Rallybio | $0.37 | 7744.2% | Jonathan Wolleben72% | → $29 | Reiterates | → Market Outperform | Get Alert |
| 02/22/2023 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 56.71% | Jonathan Wolleben72% | → $16 | Reiterates | → Market Outperform | Get Alert |
| 02/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 37.14% | Jonathan Wolleben72% | → $12 | Reiterates | → Market Outperform | Get Alert |
| 02/13/2023 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 796.29% | Jonathan Wolleben72% | → $7 | Reiterates | → Market Outperform | Get Alert |
| 02/06/2023 | ALT | Buy Now | Altimmune | $6.95 | 274.1% | Jonathan Wolleben72% | → $26 | Reiterates | → Market Outperform | Get Alert |
| 01/24/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 457.49% | Jonathan Wolleben72% | $16 → $16 | Maintains | Market Outperform | Get Alert |
| 01/11/2023 | PHVS | Buy Now | Pharvaris | $18.81 | 22.28% | Jonathan Wolleben72% | $22 → $23 | Maintains | Market Outperform | Get Alert |
| 01/09/2023 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 37.14% | Jonathan Wolleben72% | $25 → $12 | Maintains | Market Outperform | Get Alert |
| 01/08/2023 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 10696.22% | Jonathan Wolleben72% | $8 → $8 | Maintains | Outperform | Get Alert |
| 01/05/2023 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 36.81% | Jonathan Wolleben72% | $312 → $390 | Maintains | Market Outperform | Get Alert |
| 12/20/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | 9.45% | Jonathan Wolleben72% | $182 → $312 | Maintains | Market Outperform | Get Alert |
| 12/09/2022 | PHVS | Buy Now | Pharvaris | $18.81 | 16.96% | Jonathan Wolleben72% | $18 → $22 | Maintains | Market Outperform | Get Alert |
| 11/16/2022 | SPRB | Buy Now | Spruce Biosciences | $0.07 | 10696.22% | Jonathan Wolleben72% | → $8 | Initiates | → Market Outperform | Get Alert |
| 11/11/2022 | AURA | Buy Now | Aura Biosciences | $6.40 | 368.75% | Jonathan Wolleben72% | $26 → $30 | Maintains | Market Outperform | Get Alert |
| 11/11/2022 | ALT | Buy Now | Altimmune | $6.95 | 274.1% | Jonathan Wolleben72% | $28 → $26 | Maintains | Market Outperform | Get Alert |
| 09/19/2022 | LRMR | Buy Now | Larimar Therapeutics | $2.87 | 457.49% | Jonathan Wolleben72% | $10 → $16 | Maintains | Market Outperform | Get Alert |
| 08/25/2022 | PTGX | Buy Now | Protagonist Therapeutics | $54.66 | -61.58% | Jonathan Wolleben72% | → $21 | Reinstates | → Market Outperform | Get Alert |
| 08/09/2022 | RLYB | Buy Now | Rallybio | $0.37 | 9096.65% | Jonathan Wolleben72% | $29 → $34 | Maintains | Market Outperform | Get Alert |
| 08/09/2022 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 185.71% | Jonathan Wolleben72% | $20 → $25 | Maintains | Market Outperform | Get Alert |
| 07/19/2022 | AURA | Buy Now | Aura Biosciences | $6.40 | 306.25% | Jonathan Wolleben72% | → $26 | Initiates | → Market Outperform | Get Alert |
| 05/25/2022 | PHVS | Buy Now | Pharvaris | $18.81 | 80.75% | Jonathan Wolleben72% | → $34 | Initiates | → Market Outperform | Get Alert |
| 05/10/2022 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 128.57% | Jonathan Wolleben72% | $22 → $20 | Maintains | Market Outperform | Get Alert |
| 05/10/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | -40.36% | Jonathan Wolleben72% | $200 → $170 | Maintains | Market Outperform | Get Alert |
| 04/14/2022 | PRQR | Buy Now | ProQR Therapeutics | $1.88 | 165.96% | Jonathan Wolleben72% | $8 → $5 | Maintains | Market Outperform | Get Alert |
| 03/31/2022 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 44.23% | Jonathan Wolleben72% | $43 → $45 | Maintains | Market Outperform | Get Alert |
| 03/16/2022 | RLYB | Buy Now | Rallybio | $0.37 | 7744.2% | Jonathan Wolleben72% | $32 → $29 | Maintains | Market Outperform | Get Alert |
| 03/11/2022 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 1180.41% | Jonathan Wolleben72% | $11 → $10 | Maintains | Market Outperform | Get Alert |
| 03/01/2022 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 151.43% | Jonathan Wolleben72% | $30 → $22 | Maintains | Market Outperform | Get Alert |
| 02/22/2022 | RLYB | Buy Now | Rallybio | $0.37 | 8555.67% | Jonathan Wolleben72% | → $32 | Initiates | → Market Outperform | Get Alert |
| 02/14/2022 | PRQR | Buy Now | ProQR Therapeutics | $1.88 | 325.53% | Jonathan Wolleben72% | $29 → $8 | Maintains | Market Outperform | Get Alert |
| 12/21/2021 | DBVT | Buy Now | DBV Technologies | $9.53 | -47.53% | Jonathan Wolleben72% | $8 → $5 | Maintains | Market Outperform | Get Alert |
| 11/30/2021 | CRNX | Buy Now | Crinetics Pharmaceuticals | $31.20 | 37.82% | Jonathan Wolleben72% | → $43 | Initiates | → Market Outperform | Get Alert |
| 11/09/2021 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 242.86% | Jonathan Wolleben72% | $27 → $30 | Maintains | Market Outperform | Get Alert |
| 09/09/2021 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | 277.14% | Jonathan Wolleben72% | $30 → $33 | Maintains | Market Outperform | Get Alert |
| 08/06/2021 | BCRX | Buy Now | BioCryst Pharma | $10.21 | 125.27% | Jonathan Wolleben72% | $22 → $23 | Maintains | Market Outperform | Get Alert |
| 06/30/2021 | ALT | Buy Now | Altimmune | $6.95 | 346.04% | Jonathan Wolleben72% | $53 → $31 | Maintains | Market Outperform | Get Alert |
| 06/16/2021 | ALT | Buy Now | Altimmune | $6.95 | 662.59% | Jonathan Wolleben72% | $45 → $53 | Maintains | Market Outperform | Get Alert |
| 06/15/2021 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 1052.37% | Jonathan Wolleben72% | $8 → $9 | Maintains | Market Outperform | Get Alert |
| 05/25/2021 | SBBP | Buy Now | Strongbridge Biopharma | — | — | Jonathan Wolleben72% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/28/2020 | ALT | Buy Now | Altimmune | $6.95 | 619.42% | Jonathan Wolleben72% | → $50 | Initiates | → Market Outperform | Get Alert |
| 11/13/2019 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | -20% | Jonathan Wolleben72% | $9 → $7 | Maintains | Market Outperform | Get Alert |
| 12/20/2018 | DBVT | Buy Now | DBV Technologies | $9.53 | 109.86% | Jonathan Wolleben72% | $30 → $20 | Reiterates | → Market Outperform | Get Alert |
| 05/25/2017 | CLSD | Buy Now | Clearside Biomedical | $0.78 | 2588.86% | Jonathan Wolleben72% | → $21 | Initiates | → Market Outperform | Get Alert |
| 01/03/2017 | MDGL | Buy Now | Madrigal Pharmaceuticals | $285.06 | — | Jonathan Wolleben72% | — | Initiates | → Outperform | Get Alert |
| 08/11/2016 | OCUL | Buy Now | Ocular Therapeutix | $8.75 | — | Jonathan Wolleben72% | — | Initiates | → Outperform | Get Alert |
| 03/15/2016 | PRQR | Buy Now | ProQR Therapeutics | $1.88 | 644.68% | Jonathan Wolleben72% | $24 → $14 | Maintains | Market Outperform | Get Alert |
| 10/14/2014 | PRQR | Buy Now | ProQR Therapeutics | $1.88 | 1814.89% | Jonathan Wolleben72% | → $36 | Initiates | → Market Outperform | Get Alert |
